CA3027876A1 - Compositions et procedes de cannabis - Google Patents

Compositions et procedes de cannabis Download PDF

Info

Publication number
CA3027876A1
CA3027876A1 CA3027876A CA3027876A CA3027876A1 CA 3027876 A1 CA3027876 A1 CA 3027876A1 CA 3027876 A CA3027876 A CA 3027876A CA 3027876 A CA3027876 A CA 3027876A CA 3027876 A1 CA3027876 A1 CA 3027876A1
Authority
CA
Canada
Prior art keywords
pellet
cannabis
pharmaceutical composition
cbda
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3027876A
Other languages
English (en)
Inventor
Guy Chamberland
Andrien Rackov
Diane Botelho
Randy Ringuette
Charles Campbell
Keith Dias
Ofer Yifrach-Stav
Gary Leong
Mary Jo Camboia
Peter Ford
Original Assignee
Tetra Bio Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetra Bio Pharma filed Critical Tetra Bio Pharma
Priority to CA3027876A priority Critical patent/CA3027876A1/fr
Priority to PCT/CA2019/051833 priority patent/WO2020124220A1/fr
Priority to AU2019409889A priority patent/AU2019409889A1/en
Priority to US17/415,258 priority patent/US20220054447A1/en
Priority to CA3115179A priority patent/CA3115179A1/fr
Priority to EP19899449.3A priority patent/EP3897615A4/fr
Publication of CA3027876A1 publication Critical patent/CA3027876A1/fr
Priority to IL283850A priority patent/IL283850A/en
Priority to US19/064,863 priority patent/US20260021121A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3027876A 2018-12-18 2018-12-18 Compositions et procedes de cannabis Abandoned CA3027876A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA3027876A CA3027876A1 (fr) 2018-12-18 2018-12-18 Compositions et procedes de cannabis
PCT/CA2019/051833 WO2020124220A1 (fr) 2018-12-18 2019-12-17 Compositions de cannabis et méthodes
AU2019409889A AU2019409889A1 (en) 2018-12-18 2019-12-17 Cannabis compositions and methods
US17/415,258 US20220054447A1 (en) 2018-12-18 2019-12-17 Cannabis compositions and methods
CA3115179A CA3115179A1 (fr) 2018-12-18 2019-12-17 Compositions de cannabis et methodes
EP19899449.3A EP3897615A4 (fr) 2018-12-18 2019-12-17 Compositions de cannabis et méthodes
IL283850A IL283850A (en) 2018-12-18 2021-06-09 Cannabis compositions and methods
US19/064,863 US20260021121A1 (en) 2018-12-18 2025-02-27 Cannabis compositions and methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3027876A CA3027876A1 (fr) 2018-12-18 2018-12-18 Compositions et procedes de cannabis

Publications (1)

Publication Number Publication Date
CA3027876A1 true CA3027876A1 (fr) 2020-06-18

Family

ID=71100130

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3027876A Abandoned CA3027876A1 (fr) 2018-12-18 2018-12-18 Compositions et procedes de cannabis
CA3115179A Pending CA3115179A1 (fr) 2018-12-18 2019-12-17 Compositions de cannabis et methodes

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3115179A Pending CA3115179A1 (fr) 2018-12-18 2019-12-17 Compositions de cannabis et methodes

Country Status (6)

Country Link
US (2) US20220054447A1 (fr)
EP (1) EP3897615A4 (fr)
AU (1) AU2019409889A1 (fr)
CA (2) CA3027876A1 (fr)
IL (1) IL283850A (fr)
WO (1) WO2020124220A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022008571A (es) 2020-01-10 2022-11-30 Real Isolates Llc Metodos para la obtencion de compuestos a partir de un material vegetal o de hongos, composiciones respectivas y usos de los mismos.
US20230218566A1 (en) * 2020-06-12 2023-07-13 Zelira Therapeutics Operations Pty Ltd Composition and Method for Treating Chronic Pain
WO2022082052A1 (fr) * 2020-10-15 2022-04-21 Dynavap, LLC Comprimé de biomasse et procédé et appareil de formation de celui-ci
US20240316074A1 (en) * 2021-07-02 2024-09-26 Oregon State University Methods of treating or preventing coronavirus infection with cannabinoid acids
GB202110543D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014145490A2 (fr) * 2013-03-15 2014-09-18 Biotech Institute, Llc Sélection, production, traitement et utilisation de cannabis spécialisé
AU2015232994B2 (en) * 2014-03-18 2020-05-28 Izun Pharmaceuticals Corp. Protein-bound cannabinoid compositions
US20180154103A1 (en) * 2015-05-22 2018-06-07 Compressed Perforated Puck Technologies Inc. Vaporizer apparatus for compressed tablet and loose fill plant source materials
US20170202895A1 (en) * 2016-01-18 2017-07-20 Kevin Anthony Hugh Cannabis Pellets
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
AU2018286647B2 (en) * 2017-06-19 2024-03-28 Zelira Therapeutics Operations Pty Ltd Sleep disorder compositions and treatments thereof
US11179340B2 (en) * 2017-12-29 2021-11-23 TGC Network LLC Cannabidiol dosage form
CA3094140A1 (fr) * 2018-03-19 2019-10-03 Emerald Health Therapeutics Canada Inc. Palet de cannabis a dose definie

Also Published As

Publication number Publication date
US20260021121A1 (en) 2026-01-22
CA3115179A1 (fr) 2020-06-25
EP3897615A1 (fr) 2021-10-27
WO2020124220A1 (fr) 2020-06-25
EP3897615A4 (fr) 2022-08-24
US20220054447A1 (en) 2022-02-24
IL283850A (en) 2021-07-29
AU2019409889A1 (en) 2021-07-15

Similar Documents

Publication Publication Date Title
US20260021121A1 (en) Cannabis compositions and methods
Hazekamp et al. Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol
Taschwer et al. Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria–Impact of different storage temperatures on stability
WO2016004121A1 (fr) Souches de cannabis à teneur élevée en cannabidiol
US11793769B2 (en) Device with compositions for delivery to the lungs, the oral mucosa and the brain
JP2023078465A (ja) 大麻抽出物ならびにその調製方法および使用方法
Majekodunmi et al. Formulation of the extract of the stem bark of Alstonia boonei as tablet dosage form
EP3474844B1 (fr) Forme pharmaceutique destinée à être vaporisée et fumée
Romano et al. An overview of galenic preparation methods for medicinal cannabis
Weathers et al. Changes in key constituents of clonally propagated Artemisia annua L. during preparation of compressed leaf tablets for possible therapeutic use
WO2020016660A2 (fr) Cigarette de cannabis à marquages de dose
ES3022483T3 (en) New cannabis compositions and industrial methods for production thereof
WO2019180505A1 (fr) Capsule de cannabis à dose définie
US10946307B2 (en) Extraction of cannabinoids, curcuminoids and ginsenosides
Gopal et al. Investigation of in-vitro anti-oxidant, anti-inflammatory and anti-arthritic activity of aerial parts of Securinega leucopyrus (Willd.) Muell
US20190241537A1 (en) Odorless Cannabis Products and Processes for Their Preparation
Carrara et al. Development of a Vaping Machine for the Sampling of THC and CBD Aerosols Generated by Two Portable Dry Herb Cannabis Vaporisers
Janković et al. Smoking of Gentiana lutea leaves: Validation of its traditional use
Rana et al. Drying potential of leaves oil of DC from North India
CN1919232A (zh) 超临界二氧化碳提取薄荷油的方法
Ballentine Chemical characterization of Pseudognaphalium obtusifolium by gas chromatography-mass spectrometry (GC-MS) to assess potential therapeutic phytochemicals and toxicological concerns using simulated use conditions
CN110404028A (zh) 一种小儿清肺颗粒及其制备方法
Wigglesworth Vaping Synthetic Cannabinoids: Degradation Study and Putative Production of Toxic Compounds
Pandey Comparative evaluation of Ayurvedic nebulizing fluid for antihistaminic and antitussive activity
Owen Investigation of the elemental profiles of Hypericum perforatum as used in herbal remedies

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20230620